How can we, humans, look at our relationship to nature differently? In season three of Going Wild, on top of stories about animals, we invite you to journey through the entire ecological web — from the tiniest of life forms to apex predators — alongside the scientists, activists and adventurers who study it. Wildlife biologist and host Dr. Rae Wynn-Grant has been studying wild animals in their natural habitats all over the world for years. Our award-winning podcast takes you inside the hidde ...
…
continue reading
محتوای ارائه شده توسط Sano Genetics. تمام محتوای پادکست شامل قسمتها، گرافیکها و توضیحات پادکست مستقیماً توسط Sano Genetics یا شریک پلتفرم پادکست آنها آپلود و ارائه میشوند. اگر فکر میکنید شخصی بدون اجازه شما از اثر دارای حق نسخهبرداری شما استفاده میکند، میتوانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Player FM - برنامه پادکست
با برنامه Player FM !
با برنامه Player FM !
EP 114: The Biggest Stories of 2023 with Dr. Veera Rajagopal (Part 1)
Manage episode 390778420 series 2631947
محتوای ارائه شده توسط Sano Genetics. تمام محتوای پادکست شامل قسمتها، گرافیکها و توضیحات پادکست مستقیماً توسط Sano Genetics یا شریک پلتفرم پادکست آنها آپلود و ارائه میشوند. اگر فکر میکنید شخصی بدون اجازه شما از اثر دارای حق نسخهبرداری شما استفاده میکند، میتوانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
0:00 Introduction
1:30 Veera’s personal highlights of 2023
1:30 Veera’s personal highlights of 2023
- Publication in Nature Genetics: Rare coding variants in CHRNB2 reduce the likelihood of smoking, an exome-wide association study identifying rare coding variants in CHRNB2 that may reduce the likelihood of smoking.
- Designing cover art
- Genetic links to neural circuits and their role in addiction
10:50 The most exciting story of the year: the first successful translation of a GWAS discovery into medicine
- A milestone year in GWAS-driven drug development: FDA Approval of Casgevy, a cell based gene therapy for the BCL11A transcription factor, in the US and UK to treat sickle cell disease
- Strong genetic support for the ongoing development of APOL1 inhibitors to treat kidney disease
- Additional disease modifier variants, including the APOE4 variant in Alzhemer’s Disease
34:52 How rare Mendelian diseases can offer insights into drug developments
- Looping back to BCL11A: how neurodevelopmental disorder patients with BCL11A haploinsufficiency provided insights into sickle cell treatment
- BCL11A knockdown to induce fetal hemoglobin production and alleviate sickle cell disease
- Recessive mutations in HMGCR provide the missing link into why statins can induce myopathy. Learn more in this Atlantic article.
- The often underappreciated importance of studying rare Mendelian diseases
51:31 The value of common variants vs rare variants in informing drug targets
- Why are pharmaceutical companies studying rare variants?
- How the FTO locus associated with obesity highlights challenges in identifying causal gene variants
- Surprising twists in translating mice physiology to human physiology, and decades-long quest to understanding the mechanism behind this extremely early GWAS hit
1:00:32 Genetic drift, endogamy, and consanguinity
- The rise of large-scale studies looking beyond European populations
- The FinnGen study: a significant step forward in understanding the genetic basis of diseases in founder populations
- Interesting discoveries from integrating non-European populations in biobanks and Direct to Consumer databases
- A recent 23andMe paper that identifies a founder variant in Puerto Rican populations associated with a strong risk effect on cataract development
1:13:40 Concluding remarks and looking ahead to Part 2!
Check out Veera's substack, GWAS Stories, and follow him on Twitter, @doctorveera
182 قسمت
Manage episode 390778420 series 2631947
محتوای ارائه شده توسط Sano Genetics. تمام محتوای پادکست شامل قسمتها، گرافیکها و توضیحات پادکست مستقیماً توسط Sano Genetics یا شریک پلتفرم پادکست آنها آپلود و ارائه میشوند. اگر فکر میکنید شخصی بدون اجازه شما از اثر دارای حق نسخهبرداری شما استفاده میکند، میتوانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
0:00 Introduction
1:30 Veera’s personal highlights of 2023
1:30 Veera’s personal highlights of 2023
- Publication in Nature Genetics: Rare coding variants in CHRNB2 reduce the likelihood of smoking, an exome-wide association study identifying rare coding variants in CHRNB2 that may reduce the likelihood of smoking.
- Designing cover art
- Genetic links to neural circuits and their role in addiction
10:50 The most exciting story of the year: the first successful translation of a GWAS discovery into medicine
- A milestone year in GWAS-driven drug development: FDA Approval of Casgevy, a cell based gene therapy for the BCL11A transcription factor, in the US and UK to treat sickle cell disease
- Strong genetic support for the ongoing development of APOL1 inhibitors to treat kidney disease
- Additional disease modifier variants, including the APOE4 variant in Alzhemer’s Disease
34:52 How rare Mendelian diseases can offer insights into drug developments
- Looping back to BCL11A: how neurodevelopmental disorder patients with BCL11A haploinsufficiency provided insights into sickle cell treatment
- BCL11A knockdown to induce fetal hemoglobin production and alleviate sickle cell disease
- Recessive mutations in HMGCR provide the missing link into why statins can induce myopathy. Learn more in this Atlantic article.
- The often underappreciated importance of studying rare Mendelian diseases
51:31 The value of common variants vs rare variants in informing drug targets
- Why are pharmaceutical companies studying rare variants?
- How the FTO locus associated with obesity highlights challenges in identifying causal gene variants
- Surprising twists in translating mice physiology to human physiology, and decades-long quest to understanding the mechanism behind this extremely early GWAS hit
1:00:32 Genetic drift, endogamy, and consanguinity
- The rise of large-scale studies looking beyond European populations
- The FinnGen study: a significant step forward in understanding the genetic basis of diseases in founder populations
- Interesting discoveries from integrating non-European populations in biobanks and Direct to Consumer databases
- A recent 23andMe paper that identifies a founder variant in Puerto Rican populations associated with a strong risk effect on cataract development
1:13:40 Concluding remarks and looking ahead to Part 2!
Check out Veera's substack, GWAS Stories, and follow him on Twitter, @doctorveera
182 قسمت
همه قسمت ها
×به Player FM خوش آمدید!
Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.